Oral presentation

Host immune signatures as predictors of response to immunotherapy-based regimens in metastatic renal cell carcinoma

OncLive National Fellows Forum: Genitourinary Cancers 2024 January 24, 2024 San Francisco, CA, USA

Presenting work evaluating host immune gene-expression signatures as predictors of response to ICI-based regimens in metastatic RCC.

Back to presentations